ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $814,000 | -40.7% | 20,130 | -15.6% | 0.01% | -37.5% |
| Q2 2015 | $1,373,000 | -12.6% | 23,861 | -3.3% | 0.02% | -11.1% |
| Q1 2015 | $1,571,000 | +6.9% | 24,678 | +3.7% | 0.02% | 0.0% |
| Q4 2014 | $1,469,000 | +104.6% | 23,790 | +28.6% | 0.02% | +100.0% |
| Q3 2014 | $718,000 | +51.8% | 18,503 | +34.8% | 0.01% | +12.5% |
| Q2 2014 | $473,000 | +15.9% | 13,723 | +45.3% | 0.01% | +14.3% |
| Q1 2014 | $408,000 | – | 9,445 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crosspoint Capital Strategies, LLC | 600 | $37,000 | 0.01% |
| PRENTISS SMITH & CO INC | 200 | $12,000 | 0.01% |
| MARSHALL & SULLIVAN INC /WA/ | 100 | $4,000 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |